Related Experiment Video
Updated: May 27, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD.
A S Pickard1, T A Lee, C T Solem
1Center for Pharmacoeconomic Research and Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA. pickard1@uic.edu
Funding agencies and researchers prioritize comparative-effectiveness research (CER) by involving experts and stakeholders. This process ensures that research questions yield relevant and implementable findings, as demonstrated in chronic obstructive pulmonary disease (COPD) studies.
Area of Science:
- Health Services Research
- Comparative Effectiveness Research
Background:
- Comparative-effectiveness research (CER) is a priority for funding agencies and researchers.
- Ensuring the relevance and implementability of CER findings is crucial for practical application.
Purpose of the Study:
- To describe a process for involving experts and stakeholders in identifying and prioritizing CER studies.
- To illustrate this process using an example from chronic obstructive pulmonary disease (COPD) research.
Main Methods:
- A systematic process was developed to engage experts and stakeholders.
- This process focused on the identification and prioritization of CER research questions.
- The application of this process was demonstrated within the context of COPD.
Main Results:
- The described process facilitates the selection of high-priority CER topics.
- Stakeholder and expert involvement enhances the relevance of research questions.
- The methodology proved effective in the context of chronic obstructive pulmonary disease.
Conclusions:
- A structured approach involving experts and stakeholders is effective for prioritizing CER studies.
- This method ensures that research addresses critical needs and is feasible for implementation.
- The findings are applicable to improving the impact of CER, particularly in areas like COPD.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
